Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... use among cytotoxic agents was found for exposure to cyclophosphamide (OR, 3.58; 95% CI, 0.91-14.11) followed by mitoxantrone ...

    Research Article last updated 02/03/2017 - 1:25pm.

  2. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

    ... BACKGROUND: Cyclophosphamide -based conditioning regimens and allogeneic hematopoietic ... with high (200 mg/kg) and low (60 mg/kg) dose cyclophosphamide as upfront treatment in newly diagnosed pediatric patients ...

    Research Article last updated 04/09/2014 - 9:11am.

  3. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.

    ... immunosuppressive therapy, and high-dose cyclophosphamide . Here, we report long-term follow-up on 67 SAA patients ... and 23 refractory ) treated with high-dose cyclophosphamide. At 10 years, the overall actuarial survival was 88%, the ... with refractory SAA fared less well after high-dose cyclophosphamide therapy; at 10 years, overall actuarial survival, response, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

    ... treatment. Recently, fludarabine , lower-dose cyclophosphamide and antithymocyte globulin conditioning ...

    Research Article last updated 11/28/2016 - 9:28am.

  5. Long-term follow-up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

    ... we decided some years ago to use the combination of cyclophosphamide and antithymocyte globulin . We report the ... transplanted from June 1991 to February 2010, following cyclophosphamide (200mg/kg) and antithymocyte globulin (2.5 mg/kg/day x 5 ...

    Research Article last updated 01/09/2012 - 10:43am.

  6. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

    ... the efficacy and safety of allo-HSCT with high-dose cyclophosphamide -induced immune tolerance for SAA. In the present study, 20 ... fludarabine combined with Busulfex and cytarabine, cyclophosphamide. Cyclophosphamide (50 mg/kg/d) induced immune tolerance ...

    Research Article last updated 11/01/2016 - 1:59pm.

  7. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party.

    ... received either a combination of fludarabine , cyclophosphamide , and antithymocyte globulin (n=52, median age 13 ... survival was 73% for the group that received fludarabine, cyclophosphamide, and antithymocyte globulin and 79% for the group given the ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplantation in severe aplastic anemia

    ... (BMT) in severe aplastic anemia (SAA) is cyclophosphamide (CY) and horse antithymocyte globulin (ATG). Horse ...

    Research Article last updated 07/31/2012 - 2:18pm.

  9. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

    ... (n=29), using fludarabine 30mg/m(2) for 4 days, cyclophosphamide 300mg/m(2) for 4 days and alemtuzumab median total dose ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single-center study

    ... and the conditioning regimen was Bu/Cy (busulfan plus cyclophosphamide ), and the source of stem cells was peripheral ...

    Research Article last updated 11/02/2016 - 10:41am.